Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Susan Saline who wrote (9622)	5/22/1998 12:06:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

MDT...Medtronic Announces a New Family of Pacemaker Leads<MDT.N> MACD still bearish but volume indicators show MDT is now under accumulations. Price is above resistance of 50 7/8. Looks like a nice 'turnaround' chart and strong stock. Medtronic Announces a New Family of Pacemaker Leads More Than One Million Medtronic CapSure(R) Leads Implanted MINNEAPOLIS, May 21 /PRNewswire/ -- Medtronic, Inc. (NYSE: MDT), today announced the commercial release in Europe and Canada of a new family of bradycardia pacing leads designed to facilitate ease of pacemaker lead implantation. The new Medtronic CapSure(R) SP Novus(TM) leads offer the benefit of small size, while continuing to build on the proven steroid performance of the world's most frequently implanted pacing leads, the Medtronic CapSure SP lead family. The CapSure SP lead family has demonstrated excellent acute and chronic electrical performance and long-term reliability. Leads are insulated wires that carry precisely controlled electrical impulses from the pacemaker implanted in the upper chest to the inner wall of the heart. They are crucial to effective pacing for the millions worldwide who now wear cardiac pacemakers. The CapSure SP Novus line provides a choice for physicians, with both silicone and polyurethane models available for pacing in the atrium and the ventricle. The silicone CapSure SP Novus leads feature a new, smaller diameter lead body because of new proprietary silicone insulation. The polyurethane leads offer the handling and size advantages preferred by many physicians while their inner silicone insulation provides flexibility. "Novus leads are designed to match the long-term performance of CapSure SP, currently the world's gold standard in pacing leads," said Warren Watson, vice president and general manager of Medtronic's bradycardia leads product line. "With the addition of the CapSure SP Novus line, Medtronic continues to offer the industry's most comprehensive selection of leads." More than one million Medtronic steroid-eluting leads have been implanted, making them the most implanted lead systems in the world. Medtronic's steroid technology has demonstrated acute and chronic effectiveness in reducing pacing thresholds for more than 10 years. Because of continued growth in pacemaker lead sales, Medtronic is also announcing plans for an $11 million expansion of its leads manufacturing facility at Villalba, Puerto Rico. Medtronic Inc., headquartered in Minneapolis, is the world's leading medical technology company specializing in implantable and interventional therapies.

To: Susan Saline who wrote (9622)	5/22/1998 12:18:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

AZO.. Similar chart patterns to MDT. Volume and MFI look up now and stock is under ACCUMULATION. AZO reports earnings on 25th. AZO has a EPS rank of 87 with a projected rank of 96. ERG is very high. AZO has had bearishe relative strength in the last week but it's beginning to turn around. the major factor I like about AZO is is PROJECTED earnings going forward for the current and next quarter. While some analysts' are revising earnings downwards, especially in tech stector this company is getting stronger.